Johnson & Johnson Reports Q4 and Full-Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Johnson & Johnson (JNJ) PT Raised to $163 at Goldman Sachs
January 26, 2022 7:36 AM ESTGoldman Sachs analyst Chris Shibutani raised the price target on Johnson & Johnson (NYSE: JNJ) to $163.00 (from $161.00) while maintaining a Neutral rating.
... MoreJohnson & Johnson (JNJ) Tops Q1 EPS by 1c
January 25, 2022 6:28 AM ESTJohnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.13, $0.01 better than the analyst estimate of $2.12. Revenue for the quarter came in at $24.8 billion versus the consensus estimate of $25.29 billion.
GUIDANCE:
Johnson & Johnson sees FY2022 EPS of $10.40-$10.60, versus the consensus of... More
